Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial. - Dam T; Boxer AL; Golbe LI; Höglinger GU; Morris HR; Litvan I; Lang AE; Corvol JC; Aiba I; Grundman M; Yang L; Tidemann-Miller B; et al. (Nature medicine, 2023)